Keyphrases
Mantle Cell Lymphoma
100%
Magnetic Resonance Imaging
100%
Metabolic Changes
100%
Xenograft Model
100%
AcidoCEST
100%
Mammalian Target of Rapamycin Inhibition
100%
Tumor
80%
Initiating Treatment
40%
Phosphoinositide 3-kinase (PI3K)
20%
Tumor Growth
20%
Response to Therapy
20%
Mammalian Target of Rapamycin Pathway
20%
AKT/mammalian Target of Rapamycin
20%
Everolimus
20%
Magnetic Resonance Imaging Study
20%
Lymphoma Cells
20%
Therapeutic Efficacy
20%
Return to Normal
20%
MTOR Inhibitor
20%
Anticancer Therapy
20%
Tumor Growth Rate
20%
B-cell Malignancies
20%
RAD001
20%
Tumor Extracellular pH
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Mantle Cell Lymphoma
100%
Mammalian Target of Rapamycin
100%
Tumor Growth
40%
Everolimus
40%
Combination Therapy
20%
Phosphatidylinositol 3 Kinase
20%
Mammalian Target of Rapamycin Inhibitor
20%
Medicine and Dentistry
Granta-519 Cell Line
16%
Mantle Cell Lymphoma Cell Line
16%